These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2194042)

  • 61. Heart transplantation in Norway. Morphological monitoring of cardiac allograft rejection. A 3-year follow-up.
    Foerster A; Simonsen S; Frøysaker T
    APMIS; 1988 Jan; 96(1):14-24. PubMed ID: 3278719
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Imaging in patients after cardiac transplantation and in patients with ventricular assist devices.
    Gupta B; Jacob D; Thompson R
    J Nucl Cardiol; 2015 Aug; 22(4):617-38. PubMed ID: 25832983
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Coronary vasomotor dysfunction in the cardiac allograft: impact of different immunosuppressive regimens.
    Weis M; Wildhirt SM; Schulze C; Pehlivanli S; Rieder G; Wolf WP; Wilbert-Lampen U; Meiser BM; Enders G; von Scheidt W
    J Cardiovasc Pharmacol; 2000 Dec; 36(6):776-84. PubMed ID: 11117379
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunoscintigraphy with 111In antimyosin Fab.
    Morguet AJ; Munz DL; Kreuzer H; Emrich D
    Nucl Med Commun; 1990 Nov; 11(11):727-35. PubMed ID: 2277688
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
    Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
    Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The noninvasive assessment of myocardial viability.
    Ragosta M; Beller GA
    Clin Cardiol; 1993 Jul; 16(7):531-8. PubMed ID: 8348761
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reduction of tricuspid annular doppler tissue velocities in pediatric heart transplant patients.
    Fyfe DA; Mahle WT; Kanter KR; Wu G; Vincent RN; Ketchum DL
    J Heart Lung Transplant; 2003 May; 22(5):553-9. PubMed ID: 12742418
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
    Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Predictors of reduced coronary flow reserve in heart transplant recipients without angiographically significant coronary artery disease.
    Klauss V; Spes CH; Rieber J; Siebert U; Werner F; Stempfle HU; Uberfuhr P; Theisen K; Angermann CE; Reichart B; Mudra H
    Transplantation; 1999 Nov; 68(10):1477-81. PubMed ID: 10589942
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Usefulness of preoperative noninvasive radionuclide testing for detecting coronary artery disease in candidates for liver transplantation.
    Kryzhanovski VA; Beller GA
    Am J Cardiol; 1997 Apr; 79(7):986-8. PubMed ID: 9104922
    [TBL] [Abstract][Full Text] [Related]  

  • 71. No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium.
    Siebelink HM; Blanksma PK; Crijns HJ; Bax JJ; van Boven AJ; Kingma T; Piers DA; Pruim J; Jager PL; Vaalburg W; van der Wall EE
    J Am Coll Cardiol; 2001 Jan; 37(1):81-8. PubMed ID: 11153777
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Chronic heart failure assessed by nuclear medicine].
    Morita K; Tamaki N
    Nihon Rinsho; 2003 May; 61(5):789-95. PubMed ID: 12755004
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tissue Doppler imaging detects severely abnormal myocardial velocities that identify children with pre-terminal cardiac graft failure after heart transplantation.
    Fyfe DA; Ketchum D; Lewis R; Sabatier J; Kanter K; Mahle W; Vincent R
    J Heart Lung Transplant; 2006 May; 25(5):510-7. PubMed ID: 16678028
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Detection of rejection of canine orthotopic cardiac allografts with indium-111 lymphocytes and gamma scintigraphy.
    Eisen HJ; Rosenbloom M; Laschinger JC; Saffitz JE; Cox JL; Sobel BE; Bolman RM; Bergmann SR
    J Nucl Med; 1988 Jul; 29(7):1223-9. PubMed ID: 3292723
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Myocardial high-energy phosphate depletion in allograft rejection after orthotopic human heart transplantation.
    Benvenuti C; Aptecar E; Deleuze P; Benaïem N; Mazzucotelli JP; Charloux C; Castaigne A; Loisance D; Astier A; Paul M
    J Heart Lung Transplant; 1994; 13(5):857-61. PubMed ID: 7803427
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antimyosin imaging in cardiac transplant rejection.
    Johnson LL; Cannon PJ
    Circulation; 1991 Sep; 84(3 Suppl):I273-9. PubMed ID: 1884496
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serial Doppler echocardiographic assessment of left and right ventricular filling for non-invasive diagnosis of mild acute cardiac allograft rejection.
    Spes CH; Schnaack SD; Schütz A; Gokel JM; Kemkes BM; Theisen K; Angermann CE
    Eur Heart J; 1992 Jul; 13(7):889-94. PubMed ID: 1644077
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Update in nuclear cardiology.
    Grambow DW; Schwaiger M
    Curr Opin Cardiol; 1993 Nov; 8(6):1014-20. PubMed ID: 10146527
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Assessment of severity of cardiac rejection in heterotopic heart transplantation using indium-111 antimyosin and magnetic resonance imaging.
    Nishimura T; Sada M; Sasaki H; Yutani C; Fujita T; Amemiya H; Kozuka T; Akutsu T; Manabe H
    Cardiovasc Res; 1988 Feb; 22(2):108-12. PubMed ID: 3048691
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Influence of corticosteroid-free maintenance immunosuppression on allograft coronary artery disease after cardiac transplantation.
    Ratkovec RM; Wray RB; Renlund DG; O'Connell JB; Bristow MR; Gay WA; Karwande SV; Doty DB; Millar RC; Menlove RL
    J Thorac Cardiovasc Surg; 1990 Jul; 100(1):6-12. PubMed ID: 2366566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.